Log In

Kiran Mazumdar-Shaw Edit Profile

entrepreneur

Background

The daughter of a brewmaster for India-based United Breweries, Mazumdar-Shaw originally planned to follow in her father’s footsteps.

Career

She started her career as a trainee brewer in Carlton & United Beverages in 1974. In 1978, she joined as Trainee Manager with Biocon Biochemicals Limited in Ireland. In the same year, Kiran Mazumdar Shaw founded Biocon India in collaboration with Biocon Biochemicals Limited, with a capital of Rs.10,000.

Biocon's initial operation was to extract an enzyme from papaya. Under Kiran Mazumdar Shaw's stewardship Biocon transformed from an industrial enzymes company to an integrated biopharmaceutical company with strategic research initiatives. Today, Biocon is recognised as India's pioneering biotech enterprise. In 2004, Biocon came up with an IPO and the issue was over-subscribed by over 30 times. Post-IPO, Kiran Mazumdar Shaw held close to 40% of the stock of the company and was regarded as India's richest woman with an estimated worth of Rs. 2,100 crore.

She helped establish a 1,400-bed cancer care center at the Narayana Health City campus at Boommasandra, Bangalore, along with Dr. Devi Shetty of Narayana Hrudayalaya in 2007. She liked the innovation model and thinking that Dr. Prasad Kaipa brought to Biocon and funded multi-year research at Indian School of Business by creating Biocon Cell for Innovation Management as part of Center for Leadership Innovation and Change.

Achievements

  • In 2001 Biocon became the first Indian company to gain the approval of the United States Food and Drug Administration (Food and Drug Administration) for the manufacture of a cholesterol-lowering molecule. After a wildly successful initial public stock offering the following year, Biocon’s stock-market value skyrocketed, and Mazumdar-Shaw, with a nearly 40-percent stake in the company, became the richest woman in India.

Connections

Husband:
John Shaw